Education
About Us
Working with TipRanks
Follow Us
VentriPoint Diagnostics Ltd (TSE:VPT)
:VPT
VPT Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.08 - C$0.20
Previous CloseN/A
Volume32.00K
Average Volume (3M)118.62K
Market Cap
C$17.61M
Enterprise ValueC$23.15M
Total Cash (Recent Filing)C$352.67K
Total Debt (Recent Filing)C$2.13M
Price to Earnings (P/E)―
Beta0.15
Next Earnings
Nov 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding167,704,010
10 Day Avg. Volume98,397
30 Day Avg. Volume118,621
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
VentriPoint Diagnostics News
VPT FAQ
What was VentriPoint Diagnostics Ltd’s price range in the past 12 months?
VentriPoint Diagnostics Ltd lowest stock price was C$0.07 and its highest was C$0.20 in the past 12 months.
What is VentriPoint Diagnostics Ltd’s market cap?
VentriPoint Diagnostics Ltd’s market cap is C$17.61M.
When is VentriPoint Diagnostics Ltd’s upcoming earnings report date?
VentriPoint Diagnostics Ltd’s upcoming earnings report date is Nov 26, 2025 which is in 81 days.
How were VentriPoint Diagnostics Ltd’s earnings last quarter?
VentriPoint Diagnostics Ltd released its earnings results on Aug 29, 2025. The company reported -C$0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.008.
Is VentriPoint Diagnostics Ltd overvalued?
According to Wall Street analysts VentriPoint Diagnostics Ltd’s price is currently Overvalued.
Does VentriPoint Diagnostics Ltd pay dividends?
VentriPoint Diagnostics Ltd does not currently pay dividends.
What is VentriPoint Diagnostics Ltd’s EPS estimate?
VentriPoint Diagnostics Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VentriPoint Diagnostics Ltd have?
VentriPoint Diagnostics Ltd has 167,704,010 shares outstanding.
What happened to VentriPoint Diagnostics Ltd’s price movement after its last earnings report?
VentriPoint Diagnostics Ltd reported an EPS of -C$0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of VentriPoint Diagnostics Ltd?
Currently, no hedge funds are holding shares in TSE:VPT
VentriPoint Diagnostics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.66%
12-Months-Change
Fundamentals
Return on Equity
207.08%
Trailing 12-Months
Asset Growth
-21.46%
Trailing 12-Months
Company Description
VentriPoint Diagnostics Ltd
Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model of the heart chamber using echocardiograms and magnetic resonance imaging images; and obtain reproducible, accurate volumetric measurement, and ejection fraction. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart issues. The company was incorporated in 2004 and is based in Toronto, Canada.
Technical Analysis
Aurora Spine
―
Perimeter Medical Imaging AI
―
Quipt Home Medical
―
Profound Medical
―
Theralase Technologies
―
Ownership Overview
0.09% Insiders
―
Mutual Funds
― Other Institutional Investors
99.91% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---